Biogen Idec Inc., a Weston company known for its multiple sclerosis drugs, said it will reduce its workforce by 13 percent, or 650 jobs, as part of cost-cutting efforts that aim to to realize annual savings of $300 million.
Biogen Idec’s workforce in Massachusetts will be pared by 86 jobs to 1,900, a roughly 4 percent cut to the company’s Bay State workforce, according to company spokeswoman Naomi Aoki. The cuts will come from all four of the company’s current sites: Weston, Cambridge, Waltham, and Wellesley. Plans call for closing of offices in Waltham and Wellesley.
Some administrative employees from the Waltham and Wellesley sites will be moved to corporate headquarters in Weston, said Aoki.
***********************************************************